-
Taxonomy & unit
-
us-gaap: CAD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Evome Medical Technologies Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q1 2021 to Q4 2023.
- Evome Medical Technologies Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2023 was CA$3.24M, a 13.1% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (CAD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)